Partner Headlines - TEVA

  1. Alder Biopharma Migraine Drug Holds Up After 6 Months

    Investors Business Daily
  2. California Leads Nation In Tech, Lifesciences IPOs

    IBD
  3. Gurus Are Buying High-Yield Stocks Like WestRock, Target

    GuruFocus
  4. Top Stocks 2015: Biotechs, Wayfair, Netflix, Amazon

    IBD
  5. Takeda Provides Update About New Business Venture in Japan with ...

    Benzinga
  6. 5 Guru Picks in Volatile Biotech Industry

    GuruFocus
  7. NWQ Managers Reduces Stakes in Microsoft, MetLife and Teva Pharmaceutical

    GuruFocus
  8. Benzinga's Top Initiations

    Benzinga
  9. GoPro PT Cut; Chipotle, Bluebird Bio Downgraded

    IBD
  10. Benzinga's Volume Movers

    Benzinga
  11. Top Performing Industries For December 1, 2015

    Benzinga
  12. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga
  13. Teva Announces Proposed Public Offerings Of Amer Depositary Shrs ...

    Benzinga
  14. Teva, Takeda Establish Partnership in Japan; Teva to Own 51% ...

    Benzinga
  15. Teva, Heptares Announce Agreement to Discover and Develop Novel, ...

    Benzinga
  16. Benzinga's Top Upgrades

    Benzinga
  17. Pfizer, Allergan Set To Unveil $150 Billion Inversion

    IBD
  18. John Paulson Increases Holding in Teva Pharmaceutical

    GuruFocus
  19. John Paulson Keeps Gold, Buys Drug Manufacturers in Q3

    GuruFocus
  20. Mylan, Perrigo Face Off As Takeover Vote Nears

    IBD
  21. Ronald Muhlenkamp's Highest-Yielding Stocks

    GuruFocus
  22. Teva Announces Breakthrough Therapy Designation for SD-809 Granted ...

    Benzinga
  23. Allergan Beats Q3 Estimates Amid M&A, Pricing Talk

    IBD
  24. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD
  25. Allergan Confirms Pfizer Talks

    IBD
  26. Teva Pharmaceutical's

    IBD
  27. Ah the Joys of Theft - My Purloined Portfolio

    GuruFocus
  28. Here's Why Biotechs Fell On Monday

    Benzinga
  29. Teva Launches Generic Avodart Capsules in the US

    Benzinga
  30. Neurocrine Tardive Dyskinesia Drug Hits, Stock Jumps

    IBD
  31. Acorda, Allergan Make Surprise Deal On Ampyra Patent

    IBD
  32. Benzinga's M&A Chatter for Thursday October 1, 2015

    Benzinga
  33. Allergan Guidance Update Gets Mixed Reception

    IBD
  34. U.S. M&A Hits Record As Companies Try To Grow Sales

    IBD
  35. Teva Announces COPAXONE Approved in Japan for Prevention of Relapse ...

    Benzinga
  36. Teva Presents New Reslizumab Data at ERS International Congress ...

    Benzinga
  37. Hedge Fund Menta Capital's Top Stocks Include Teva Pharmaceutical, ...

    GuruFocus
  38. An ETF That Provides Shelter From Stormy Markets

    Benzinga
  39. Teva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic ...

    Benzinga
  40. Mylan Confirms USPTO Institutes Inter Partes Review Proceedings ...

    Benzinga
  41. Allergan Modestly Tops Views

    IBD
  42. Allergan Q2 Beats, But Generics Sale Clouds Outlook

    IBD
  43. Israeli Tech Startups Attract Record Funding In Q2

    IBD
  44. 5 Top Medical Stocks Reporting Earnings This Week

    IBD
  45. Teva's Deal-Making Spurs Inflows To Israel ETFs

    Benzinga
  46. Benzinga's Top Upgrades

    Benzinga
  47. IBD 50: 10 Top Stocks Reporting Earnings This Week

    IBD
  48. These 4 Foreign Drug Stocks Have Broken Out Recently

    IBD
  49. 5 Hot Drug Stocks Top IBD's Big Cap Leaders Screen

    IBD
  50. Wakefulness Drug Xyrem Keeps Jazz Pharmaceuticals Up

    IBD
  51. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD
  52. Stocks In Rebound Mode; Icon, Cadence Break Out

    IBD
  53. Can Health Care Sector Continue its Incredible Run?

    FoxBusiness
  54. Weekly 52-Week Highs Highlight: GIS, AAP, BCR, TEVA

    GuruFocus
  55. Benzinga's Top Upgrades

    Benzinga
  56. Teva Announces European Medicines Agency (EMA) Confirms Successful ...

    Benzinga
  57. Teva Prefers Allergan Unit

    IBD
  58. Benzinga's M&A Chatter for Monday July 27, 2015

    Benzinga
  59. Stocks Fall For Fifth Straight Session On China Woes

    IBD
  60. Allergan CEO: Teva Made A 'Compelling Offer' We Couldn't Refuse

    Benzinga
  61. Market Update: Monday's Top 10 Volume Movers

    Benzinga
  62. Stocks Mired In Red, Hurt By China Weakness; Boot Barn Bounces

    IBD
  63. Market Update: Monday's Mid-Day Movers, China's Stock Market ...

    Benzinga
  64. Stocks In The Red But Off Lows As Shanghai, Europe Weigh

    IBD
  65. Teva Drops Mylan Chase To Buy Allergan Generics Unit

    IBD
  66. Benzinga's Volume Movers

    Benzinga
  67. Teva Confirms Allergan Generics Buy, Drops Mylan Bid

    IBD
  68. U.S. Stocks On Track For Weak Open As Chinese Stocks Sink

    IBD
  69. UPDATE: Mylan Issues Comment on Teva Deal to Buy Allergan's Generic ...

    Benzinga
  70. UPDATE: Teva Withdraws Proposal to Acquire Mylan

    Benzinga
  71. UPDATE: Teva to Acquire Allergan Generics for $40.5 B

    Benzinga
  72. Benzinga's Weekend M&A Chatter

    Benzinga
  73. Teva To Buy Allergan's Generic Drug Unit, Unit Worth ~$45B, Deal ...

    Benzinga
  74. Biotech IPO Boom Gaining Thrust With NantKwest Debut

    IBD
  75. Morning-after pill use increases

    IBD
  76. Novartis' Mixed Q2: Sandoz Booms, Alcon Struggles

    IBD
  77. Rapid7 IPO Pops 52%; Investors Hungry For Blue Buffalo

    IBD
  78. Painkiller Abuse Drives Drugmakers To Innovate

    IBD
  79. Celgene Hits High As Street Applauds Receptos Buyout

    IBD
  80. Teva-Mylan merger opposed

    IBD
  81. Benzinga's Top Initiations

    Benzinga
  82. Medicines Co., Eagle Pharma Up On Analyst Actions

    IBD
  83. Momenta Pharma

    IBD
  84. Momenta Downgraded After Stock Price Doubles

    IBD
  85. Teva-Xenon Arthritis Pain Drug Fails Midstage Trial

    IBD
  86. Wednesday's Mid-Day Movers: Chubb, Rock Creed, RADA Win; Peabody ...

    Benzinga
  87. Unusual Covered Call Opportunity Teva Pharmaceuticals

    Benzinga
  88. Alder Bio Up As Credit Suisse Lauds Migraine Drug

    IBD
  89. New America's IPO Stock Winners: Fitbit, Arista

    IBD
  90. ObamaCare Enables Health Insurer Merger Mania

    IBD
  91. Paul Tudor Jones Buys Stakes in ADP and Visa

    GuruFocus
  92. Teva Migraine Drug Succeeds In Midstage Trial

    IBD
  93. Teva Migraine Drug Succeeds In Midstage Trial

    IBD
  94. Teva to Present New Findings at the American Headache Society ...

    Benzinga
  95. How High Can Eagle Pharmaceuticals Fly On Teva Deal?

    IBD
  96. Teva's Mylan bid hits snag

    IBD
  97. Teva's Auspex Buyout Pays, But Mylan Bid Hits Snag

    IBD
  98. Teva Advances Pipeline of Movement Disorder Assets with Announcement ...

    Benzinga
  99. Top Biotech Stock Files For New Drug, In Buy Range

    IBD
  100. Activist Hedge Fund Manager Has Strong Focus on Health Care Stocks

    GuruFocus
Trading Center